FDC recalls more than 60000 bottles of glaucoma medication in US
Mumbai: Mumbai-headquartered drug firm FDC Ltd is recalling 60,428 bottles of Timolol Maleate Ophthalmic Solution in the US market over manufacturing issue, as per the US Food and Drug Administration's latest Enforcement Report.
Timolol Maleate Ophthalmic Solution is used for the treatment of glaucoma, a condition that causes damage to the optic nerve due to increased pressure in the eye.
"The company is recalling the affected lot due to "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle," the USFDA said.
Read also: Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues
This is not the first time FDC has faced such an issue. Last year, Medical Dialogues reported that the company had recalled 155,232 bottles of the same eye medication from the US market.
Read also: Dr Reddy's Labs, FDC recall generic medications in US over manufacturing issues
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.